The Rational Based Drug Design Summit Europe is the dedicated meeting bringing together structural biologists, biophysicists, medicinal chemists, computational chemists, AI drug discovery specialists ...

The WuXi agreement gives Fresenius "full strategic flexibility" to choose which biosimilar candidates to develop and gives ...

Dojolvi was approved in the US in 2020 and was also launched in Japan earlier this year. Ultragenyx recorded sales of $45 ...

A patient-led initiative for rare disease hereditary haemorrhagic telangiectasia (HHT) has won the inaugural Prix Galien ...

Marcus Evans today announced the Evolution Summit 2027, an invitation-only gathering of senior clinical trial executives, ...

Hutchmed and AstraZeneca's Orpathys is now under review in Europe and Japan for MET-driven, EGFR-mutated lung cancer, a few ...

Voceryq (doruxapapogene ralaplasmid and lalikinogene sifuplasmid) has been granted an accelerated approval by the FDA as a ...

As the only dedicated forum convening the global liquid biopsy community, the 11th Liquid Biopsy for Precision Oncology ...

Pharma companies in the UK are being invited to register their new medicines with both the MHRA and NICE at the same time, as part of a push to reduce regulatory review times by three to six months.

While praising the breadth of its pipeline, AstraZeneca has launched a three-year cost-cutting programme that will aim to ...

Belén Garijo, who took over the reins of the French pharma group in April, said this morning that Sanofi's "whole ...

Aspen Neuroscience, which is developing stem cell therapies for Parkinson's disease, sold 9.37 million shares, slightly below ...